HSBC Holdings’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

HSBC Holdings’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-19,583	Closed	-$3.38M	–	2401
2015 Q1	$3.38M	Buy	19,583 +2,975	+18%	+$437K	0.01%	1036
2014 Q4	$1.91M	Buy	16,608 +14,883	+863%	+$1.8M	﹤0.01%	1172
2014 Q3	$269K	Sell	1,725 -294,685	-99%	-$42.7M	﹤0.01%	1611
2014 Q2	$36.6M	Buy	296,410 +199,152	+205%	+$22M	0.08%	259
2014 Q1	$10.1M	Buy	97,258 +93,278	+2,344%	+$9.55M	0.02%	570
2013 Q4	$358K	Sell	3,980 -1,817	-31%	-$145K	﹤0.01%	1511
2013 Q3	$388K	Buy	5,797 +732	+14%	+$50.4K	﹤0.01%	1448
2013 Q2	$335K	Buy	+5,065	New	+$290K	﹤0.01%	1294

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

HSBC Holdings's SLXP Position: Q2 2015 in Review

HSBC Holdings sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 19,583 shares — an estimated $3.38M sold.

HSBC Holdings first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $36.6M in Q2 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

HSBC Holdings reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
HSBC Holdings sold 19,583 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $3.38M.
HSBC Holdings first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
HSBC Holdings's SALIX PHARMACEUTICALS LTD DEL position peaked at $36.6M in Q2 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on HSBC Holdings's 13F filing for Q2 2015, filed 13 Aug 2015.